MCID: HVS002
MIFTS: 14

Hiv-Associated Cancer

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Hiv-Associated Cancer

MalaCards integrated aliases for Hiv-Associated Cancer:

Name: Hiv-Associated Cancer 56
Hiv-Related Cancer 56

Characteristics:

Orphanet epidemiological data:

56
hiv-associated cancer
Inheritance: Not applicable;

Classifications:



External Ids:

Orphanet 56 ORPHA443291

Summaries for Hiv-Associated Cancer

MalaCards based summary : Hiv-Associated Cancer, is also known as hiv-related cancer. The drugs Emtricitabine and Tenofovir have been mentioned in the context of this disorder. Affiliated tissues include b cells.

Related Diseases for Hiv-Associated Cancer

Symptoms & Phenotypes for Hiv-Associated Cancer

Drugs & Therapeutics for Hiv-Associated Cancer

Drugs for Hiv-Associated Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 159)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
2
Tenofovir Phase 4 147127-20-6 464205
3 Raltegravir Potassium Phase 4
4 Reverse Transcriptase Inhibitors Phase 4
5 HIV Integrase Inhibitors Phase 4
6 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
7 Anti-HIV Agents Phase 4,Phase 2
8 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9 Integrase Inhibitors Phase 4
10 Anti-Retroviral Agents Phase 4,Phase 2
11 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
12
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
13
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
14
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
15
Bleomycin Approved Phase 3,Phase 2 11056-06-7 5360373
16
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
17
Prednisone Approved, Vet_approved Phase 3,Phase 2 53-03-2 5865
18
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
19
Daunorubicin Approved Phase 3 20830-81-3 30323
20
Cytarabine Approved, Investigational Phase 3,Phase 2 147-94-4 6253
21
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
22
Allopurinol Approved Phase 3 315-30-0 2094
23
rituximab Approved Phase 3,Phase 2 174722-31-7 10201696
24
Lenograstim Approved Phase 3,Phase 2 135968-09-1
25
Levoleucovorin Approved Phase 3,Phase 2 68538-85-2
26
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 143 6006
27
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
28
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
29 Analgesics Phase 3
30 Alkylating Agents Phase 3,Phase 2,Phase 1
31 glucocorticoids Phase 3,Phase 2
32 Central Nervous System Depressants Phase 3
33 Neurotransmitter Agents Phase 3
34 Anesthetics Phase 3
35 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
36 Hormone Antagonists Phase 3,Phase 2
37 Anesthetics, Dissociative Phase 3
38 Anesthetics, General Phase 3
39 Anesthetics, Intravenous Phase 3
40 Hormones Phase 3,Phase 2
41 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
42 Peripheral Nervous System Agents Phase 3
43 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
44 Excitatory Amino Acid Antagonists Phase 3
45 Excitatory Amino Acids Phase 3
46 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
47 Anti-Inflammatory Agents Phase 3,Phase 2
48 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
49 Antirheumatic Agents Phase 3,Phase 2
50 Antimitotic Agents Phase 3,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 58)

id Name Status NCT ID Phase Drugs
1 HIV Persistence and Viral Reservoirs Unknown status NCT01025427 Phase 4 Raltegravir, tenofovir/emtricitabine
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
4 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
5 Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART. Completed NCT02005900 Phase 3 Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART
6 A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. Completed NCT00002093 Phase 3 Daunorubicin (liposomal);Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride
7 A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma Completed NCT00000658 Phase 3 Bleomycin sulfate;Vincristine sulfate;Doxorubicin hydrochloride;Cyclophosphamide;Allopurinol;Methotrexate;Cytarabine;Leucovorin calcium;Sargramostim;Dexamethasone
8 A Study of Selumetinib in Patients With Kaposi's Sarcoma Unknown status NCT01752569 Phase 1, Phase 2 Selumetinib
9 Prospective Study on HIV-related Hodgkin Lymphoma Unknown status NCT01468740 Phase 2 Doxorubicin;Bleomycin;Vinblastine;Dacarbazine;Etoposide;Cyclophosphamide;Vincristine;Procarbazine;Prednisone
10 Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer Completed NCT01590017 Phase 2 cisplatin
11 Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma Completed NCT00049036 Phase 2 etoposide;doxorubicin hydrochloride;vincristine sulfate;prednisone;cyclophosphamide
12 Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer Completed NCT00324415 Phase 2 cisplatin;fluorouracil
13 Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Completed NCT00392834 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;liposomal cytarabine;methotrexate;therapeutic hydrocortisone;vincristine sulfate
14 Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003575 Phase 2 etoposide;ifosfamide
15 Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma Completed NCT00019123 Phase 2 thalidomide
16 Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease Completed NCT00003114 Phase 2 cyclophosphamide;etoposide;lomustine;procarbazine hydrochloride
17 Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease Completed NCT00000626 Phase 2 Vinblastine sulfate;Dacarbazine;Filgrastim;Bleomycin sulfate;Doxorubicin hydrochloride
18 A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss Completed NCT00001079 Phase 2 Testosterone enanthate;Megestrol acetate
19 Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients Completed NCT00055237 Phase 2
20 Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment Completed NCT00005811 Phase 2 topotecan hydrochloride
21 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma Completed NCT00002366 Phase 2 Ritonavir
22 Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma Recruiting NCT01771107 Phase 1, Phase 2 Brentuximab Vedotin;Dacarbazine;Doxorubicin Hydrochloride;Vinblastine
23 Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma Recruiting NCT01775475 Phase 2 cyclophosphamide;doxorubicin hydrochloride;vincristine sulfate;prednisone;lomustine;etoposide;cyclophosphamide;procarbazine hydrochloride
24 EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection Recruiting NCT00006436 Phase 2 EPOCH
25 Pomalidomide for Kaposi Sarcoma in People With or Without HIV Recruiting NCT01495598 Phase 1, Phase 2 Pomalidomide
26 A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma Recruiting NCT02298257 Phase 2 brentuximab vedotin;Doxorubicin Hydrochloride;Vinblastine;Dacarbazine
27 Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies Recruiting NCT00002663 Phase 1, Phase 2
28 Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Active, not recruiting NCT00345865 Phase 2 carmustine;cyclophosphamide;etoposide;Cytarabine
29 Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma Withdrawn NCT00024128 Phase 2 cyclophosphamide;cyclosporine
30 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
31 RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors Completed NCT01158274 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;capecitabine
32 Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00734890 Phase 1 vandetanib
33 Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Recruiting NCT02408861 Phase 1
34 Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Suspended NCT02378922 Phase 1
35 Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors Terminated NCT00112619 Phase 1 topotecan hydrochloride
36 Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer Withdrawn NCT00003435 Phase 1 melphalan
37 Screening for HIV-Associated Anal Cancer Completed NCT00188292
38 Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer Completed NCT00458562
39 Reducing HIV Stigma for African American Women Completed NCT01893112
40 Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Completed NCT00112593 fludarabine phosphate;cyclosporine;mycophenolate mofetil
41 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone Completed NCT00993694 chemotherapy;dapsone
42 Observation of the Use of QUTENZA™ in Standard Clinical Practice Completed NCT01737294 Qutenza exposure
43 Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma Completed NCT00981097
44 Evaluation of Albuminuria HIV-Infected Patients Completed NCT00524992
45 Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Recruiting NCT01567722
46 Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi Recruiting NCT03160183
47 Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use Recruiting NCT02744040 ART initiation at time of HIV diagnosis;ART at 24 weeks
48 Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses Recruiting NCT02012309
49 Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Recruiting NCT01579695 Tesamorelin for injection
50 Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study Recruiting NCT02555930

Search NIH Clinical Center for Hiv-Associated Cancer

Genetic Tests for Hiv-Associated Cancer

Anatomical Context for Hiv-Associated Cancer

MalaCards organs/tissues related to Hiv-Associated Cancer:

39
B Cells

Publications for Hiv-Associated Cancer

Articles related to Hiv-Associated Cancer:

id Title Authors Year
1
Moving forward in HIV-associated cancer. ( 24550416 )
2014
2
Pathogenesis of HIV-associated cancer. ( 25002732 )
2014
3
Pathogenesis of HIV-associated cancer. ( 25513474 )
2014
4
Biomarkers of HIV-associated Cancer. ( 25057241 )
2014
5
Anal cancer: an HIV-associated cancer. ( 12852659 )
2003

Variations for Hiv-Associated Cancer

Expression for Hiv-Associated Cancer

Search GEO for disease gene expression data for Hiv-Associated Cancer.

Pathways for Hiv-Associated Cancer

GO Terms for Hiv-Associated Cancer

Sources for Hiv-Associated Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....